Format

Send to

Choose Destination
J Formos Med Assoc. 2012 Apr;111(4):183-93. doi: 10.1016/j.jfma.2011.09.024. Epub 2012 Mar 29.

Rotavirus infection and the current status of rotavirus vaccines.

Author information

1
Department of Family Medicine, Da-Chien General Hospital, Miaoli, Taiwan.

Abstract

Among children, rotaviruses are the most common cause of severe gastroenteritis worldwide and of diarrheal deaths in developing countries. Current vaccines (e.g., Rotarix, GlaxoSmithKline Biologicals; RotaTeq, Merck and Company) effectively reduce rotaviral gastroenteritis, emergency department visits, and hospitalizations. The tremendous burden of rotavirus-related diarrhea in children across the world continues to drive the remarkable pace of vaccine development. This review assesses the global epidemiological and economic burden of rotavirus diseases, summarizes the relevant principles of the development of rotavirus vaccines, and presents data on the efficacy and effectiveness of currently licensed vaccines in both developed and developing countries.

PMID:
22526206
DOI:
10.1016/j.jfma.2011.09.024
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center